×

4: Thematic EIS investing | Matthew O’Kane of Nexus Ventures

28 Jul 2020 / Podcast Tax Advantaged

By Dr Brian Moretta

For the fourth episode of The EIS Navigator, Brian is joined by Matthew O'Kane, MD of NIVL at Nexus Ventures.

Nexus are thematic investors, so Brian and Matthew discuss how to find and invest in good themes. Matthew gives a couple of examples, showing how he built an investment thesis and how these have worked out.

Matthew joined Nexus in 2013. He devised and launched Nexus’s first EIS Fund, the Nexus Investments Scale-Up Fund, which was shortlisted for Best Generalist EIS Fund and Best Sector Specialist at the 2019 Investment Week Tax Efficiency Awards. He acts as an angel investor and active mentor to many of the UK’s brightest healthcare and education and food tech founders.

Please email [email protected] if you have any questions or comments on The EIS Navigator.

Never miss an episode – click here to subscribe to The EIS Navigator on most popular services. 

Listen now:

Links

Read Hardman & Co’s latest investment research on Nexus Investment Ventures funds here.

Visit the Nexus Investment Ventures website here.

Read about the Nexus Investment Ventures Scale-up Fund here.

Suggested reading

Dexys Midnight Runners: Young Soul Rebels – Richard White

The Second Bounce of the Ball – Ronald Cohen

Disclaimer

Please note this podcast/interview does not constitute a financial promotion and is provided for informational purposes and should not be construed as an invitation or offer to buy or sell any investments. Please be aware that investments into unquoted companies are high risk, long term and illiquid investments.  Your capital is at risk. Past performance is not a reliable indicator of future performance.  Target returns are not guaranteed and forward looking statements are illustrative only and must not be relied upon. Investors should only invest on the basis of reading the full offer documentation. Listeners must make their own independent decisions and obtain their own independent advice regarding any information, projects, securities, tax treatment or financial instruments mentioned herein.